22
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals

, , , , , , , , , , , & show all
Pages 472-479 | Received 21 Jan 2008, Accepted 16 Apr 2008, Published online: 02 Jan 2014

References

  • DuBois RN, McLane MW, Ryder K, Lau LF, Nathans D. A growth factor-inducible nuclear protein with a novel cysteine/ histidine repetitive sequence. J Biol Chem. 1990;265:19185–91.
  • Worthington MT, Amann BT, Nathans D, Berg JM. Metal binding properties and secondary structure of the zinc-binding domain of Nup475. Proc Natl Acad Sci USA. 1996;93:13754–9.
  • Lai WS, Stumpo DJ, Blackshear PJ. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem. 1990;265:16556–63.
  • Ogawa K, Chen F, Kim YJ, Chen Y. Transcriptional regulation of tristetraprolin by transforming growth factor-b in human T cells. J Biol Chem. 2003;278:30373–81.
  • Lai WS, Carballo E, Thorn JM, Kennington EA, Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA: binding of tristetraprolin-related zinc finger proteins to AU-rich ele-ments and destabilized of mRNA. J Biol Chem. 2000;275: 17827–37.
  • Carballo E, Lai WS, Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood. 2000;95:1891–9.
  • Boutaud 0, Dixon DA, Oates JA, Sawaoka H. Tristetraprolin binds to the COX-2 mRNA 3' untranslated region in cancer cells. Adv Exp Med Biol.. 2003;525: 157–60.
  • Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by triste-traprolin. Science. 1998;281:1001–5.
  • Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, et al. A pathogenetic role for TNFa in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetrapr-olin (TTP) deficiency. Immunity 1996;4:445–54.
  • Tsutsumi A, Suzuki E, Adachi Y, Murata H, Goto D, Kojo S, et al. Expression of tristetraprolin (G0524) mRNA, a regulator of TNF-a production, in synovial tissues of patients with rheumatoid arthritis. J Rheumatol. 2004;31:1044–9.
  • Taylor GA, Lai WS, Oakey RJ, Seldin MF, Shows TB, Eddy RL Jr, et al. The human TTP protein: sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res 1991;19:3454.
  • Lai WS, Thompson MJ, Taylor GA, Liu Y, Blackshear PJ. Pro-moter Analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin. J Biol Chem. 1995;270: 25266–72.
  • Lai WS, Thompson MJ, Blackshear PJ. Characteristics of the intron involvement in the mitogen-induced expression of Zfp-36. J Biol Chem. 1998;273: 506–17.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
  • Steinbrocker 0, Traeger C, Batterman R. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949;140:659–62.
  • Weyrich P, Lammers R, Fritsche A, Machicao F, Häring HU, Stefan N. A novel functional polymorphism (-336A/G) in the promoter of the partitioning-defective protein-6alpha gene is associated with increased glucose tolerance and lower concen-trations of serum non-esterified fatty acids. Diabetologia. 2005;48: 669–74.
  • Blackshear PJ, Phillips RS, Vazquez-Matias J, Mohrenweiser H. Polymorphisms in the genes encoding members of the triste-traprolin family of human tandem CCCH zinc finger proteins. Prog Nucleic Acid Res Mol Biol. 2003;75:43–68.
  • Carrick DM, Chulada P, Donn R, Fabris M, McNicholl J, Whitworth W, et al. Genetic variations in ZFP36 and their pos-sible relationship to autoimmune diseases. J Autoimmun. 2006;26:182–96.
  • Jang J, Lim DS, Choi YE, Jeong Y, Yoo SA, Kim WU, et al. MLN51 and GM-CSF involvement in the proliferation of fibro-blast-like synoviocytes in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 2006;8:R170.
  • Cook AD, Braine EL, Campbell IK, Rich MJ, Hamilton JA. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 2001;3:293–8.
  • Frasca D, Landin AM, Alvarez JP, Blackshear PJ, Riley RL, et al. Tristetraprofin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol. 2007;179:918–27.
  • Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, et al. Effects of infiiximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis. Arthritis Rheum. 2007;56:2160–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.